Concepedia

Author

Markus Riester

Dana-Farber Cancer InstituteORCID

Also Known As

M Riester, M. Riester, Markus Riester, Riester, Markus

179

Publications

7.3K

Citations

30

H-Index

76

Concepts

All Affiliations

Dana-Farber Cancer InstituteHarvard UniversityMemorial Sloan Kettering Cancer CenterNovartis (United States)City University of New York
MR

About

Markus Riester is an author at Dana-Farber Cancer Institute specializing in medicine, tumor biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

3.1K

2

Engineering

3

3

194

3

Health Sciences

2

2

99

4

Natural Sciences

2

2

1.5K

5

Public Health

2

2

228

Markus Riester

×

38

Publications

6.7K

Citations

28

H-Index

YearCitations

Specific Effects of MicroRNAs on the Plant Transcriptome

Rebecca Schwab, Javier F. Palatnik, Markus Riester,

Developmental Cell

2005

1.5K

Highly Specific Gene Silencing by Artificial MicroRNAs in <i>Arabidopsis</i>

Rebecca Schwab, Stephan Ossowski, Markus Riester,

The Plant Cell

2006

1.4K

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando, Xia Han, Catherine Tribouley,

Nature Medicine

2018

542

Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma

Tatsuya Ozawa, Markus Riester, Yu-Kang Cheng,

Cancer Cell

2014

379

JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response

Maria Kleppe, Minsuk Kwak, Priya Koppikar,

Cancer Discovery

2015

302

Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer

Markus Riester, Jennifer M. Taylor, Andrew Feifer,

Clinical Cancer Research

2012

237

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome

Benjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe‐Kains,

Database

2013

205

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts

Angelo L. Grauel, Beverly Nguyen, David A. Ruddy,

Nature Communications

2020

191

Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3

Fabrice André, Sara A. Hurvitz, Angelica Fasolo,

Journal of Clinical Oncology

2016

165

PureCN: copy number calling and SNV classification using targeted short read sequencing

Markus Riester, Angad Singh, A. Rose Brannon,

Source Code for Biology and Medicine

2016

159

Page 1